Skip to main content
. 2021 Mar 25;11(4):588. doi: 10.3390/diagnostics11040588

Table 1.

Clinical characteristics of the patient population.

All Subjects Training Cohort Testing Cohort p-Value
n 41 30 11
Age (years) 57 ± 6 58 ± 7 56 ± 3 0.57
Sex
Female 3 3 0 0.68
Male 38 27 11
Time Interval (days) 32 ± 3 32 ± 3 33 ± 3 0.48
Lymph Node Reduction (%) 66% [53–82%] 77% [53–82%] 62% [58–67%] 0.34
Lymph Node Response 0.19
Good Response (> 66%) 20 17 3
Poor Response (≤ 66%) 21 13 8
Overall Stage 0.95
IVa 39 28 11
IVb 2 2 0
T Stage 0.04
1 6 5 1
2 15 7 8
3 11 10 1
4 9 8 1
N Stage 0.75
2a 2 1 1
2b 20 14 6
2c 18 14 4
3 1 1 0

Time interval is the number of days between the pretreatment scan and follow-up scan. Change in lymph node volume was assessed at this time. Lymph node reduction is the percent change in volume of the lymph node between the pretreatment and follow-up scan. Numerical data are mean ± standard deviation or median [interquartile range].